TNF-α levels exhibited a positive correlation with HS severity and the therapeutic efficacy of TNF-α inhibitors supports the role of the dysregulated production of these cytokines in the pathophysiology of HS [77,78]. The gene discussed is TNF; the disease is histiocytic sarcoma.